The medical device safety testing market size is expected to see strong growth in the next few years. It will grow to $14.05 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth of connected and software-driven devices, tightening global regulatory frameworks, increasing investment in medical device R&D, rising demand for faster market approvals, expansion of testing needs for innovative device technologies. Major trends in the forecast period include rising demand for regulatory compliance testing, expansion of software and cybersecurity testing scope, growing complexity of connected and smart medical devices, increased outsourcing of safety testing services, harmonization of global medical device safety standards.
The rising prevalence of lifestyle-related diseases is expected to drive the growth of the medical device safety testing market in the coming years. Lifestyle-related diseases are health conditions mainly caused by an individual’s daily habits and choices, including heart disease, type 2 diabetes, obesity, hypertension, certain cancers, and mental health disorders. The incidence of lifestyle-related diseases is growing due to physical inactivity, which contributes to weight gain, poor cardiovascular health, and reduced insulin sensitivity, thereby increasing the risk of chronic illnesses. Medical device safety testing aids in managing lifestyle-related diseases by ensuring the reliability and performance of diagnostic and therapeutic devices. It improves patient safety and treatment outcomes by confirming that devices comply with regulatory standards, enhancing trust and efficiency in contemporary healthcare. For example, in June 2024, the National Health Service, a UK-based government agency, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% rise from 3,065,825 cases in 2022. Thus, the growing prevalence of lifestyle-related diseases is fueling the expansion of the medical device safety testing market.
Major companies in the medical device safety testing market are focusing on growth through technologically advanced solutions, such as state-of-the-art medical device testing facilities, to improve testing accuracy, shorten time-to-market, and ensure adherence to evolving global regulatory requirements. An advanced medical device testing facility is a specialized center or laboratory equipped with cutting-edge technology and expertise to carry out thorough testing and evaluation of medical devices. For example, in December 2023, Impelsys, an India-based technology company, inaugurated an advanced medical device testing lab in Mangalore, India. This facility utilizes AI-driven analytics and cloud-based platforms to accelerate the development of diagnostic and therapeutic devices through advanced testing, simulations, and regulatory support, highlighting its dedication to data-driven healthcare innovation.
In January 2025, Applus+ Laboratories, a Spain-based provider of testing, inspection, and certification services, acquired De.Testing for an undisclosed sum. Through this acquisition, Applus+ seeks to strengthen its presence in the fast-growing Chinese medical device market, expand its global testing capabilities, and enhance its service portfolio to deliver comprehensive, high-quality, and innovative solutions in the healthcare sector. De.Testing is a China-based company specializing in medical device safety testing.
Major companies operating in the medical device safety testing market are Thermo Fisher Scientific, Medtronic plc, Baxter International, SGS SA, Eurofins Scientific SE, Bureau Veritas SA, Bausch & Lomb, Intertek Group plc, TÜV SÜD AG, Underwriters Laboratories LLC, Applus+ Group, BSI Group, NSF International, NEMKO AS, Smithers Group Inc., Laboratory Testing Inc., JPen Medical Inc., ArchiMed, F2 Labs Inc., Medistri SA.
North America was the largest region in the medical device safety testing market in 2025. Asia-Pacific is expected to be the highest-growing region in the forecast period. The regions covered in the medical device safety testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device safety testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs impact the medical device safety testing market by increasing costs for imported testing equipment, reference devices, and calibration tools used in safety validation. Testing laboratories and manufacturers in north america, europe, and asia-pacific are most affected due to dependence on cross-border equipment sourcing. Higher tariffs can slow testing timelines and increase compliance costs. However, tariffs also encourage domestic testing infrastructure development and support regional testing service providers.
The medical device safety testing market research report is one of a series of new reports that provides medical device safety testing market statistics, including medical device safety testing industry global market size, regional shares, competitors with a medical device safety testing market share, detailed medical device safety testing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device safety testing industry. This medical device safety testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical device safety testing is the process of assessing a medical device to ensure it is safe for use by patients, healthcare providers, and others in its intended setting. This testing is performed to identify and reduce potential risks associated with electrical, mechanical, thermal, biological, and radiation hazards. Medical device safety testing ensures that the device complies with regulatory requirements and functions as intended without causing harm.
The primary services in medical device safety testing include testing, inspection, and certification. Testing involves a systematic evaluation of medical devices to verify their safety. It is applied to various types of medical devices, including active medical devices, passive medical devices, in vitro diagnostic devices, implantable devices, and surgical instruments. Technologies covered include active implantable devices, in vitro diagnostic devices, diagnostic imaging devices, and ophthalmic devices. The application areas include cardiovascular devices, orthopedic devices, neurological devices, ophthalmic devices, and dental devices. These services are utilized by hospitals, clinics, research laboratories, medical device manufacturers, and regulatory authorities.
The medical device safety testing market consists of revenues earned by entities by providing services such as product safety assessments, regulatory compliance testing, risk management analysis, performance validation, clinical trials support, environmental stress testing, material characterization, and software performance evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Medical Device Safety Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical device safety testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical device safety testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device safety testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Service Type: Testing; Inspection; Certification2) By Testing Phase: Preclinical Testing; Clinical Testing
3) By Technology: Active Implantable Devices; In Vitro Diagnostic Devices; Diagnostic Imaging Devices; Ophthalmic Devices
4) By Application: Cardiovascular Devices; Orthopedic Devices; Neurological Devices; Ophthalmic Devices; Dental Devices
5) By End User: Hospitals; Clinics; Research Laboratories; Medical Device Manufacturers; Regulatory Bodies
Subsegments:
1) By Testing: Electrical Safety Testing; Electromagnetic Compatibility (EMC) Testing; Biocompatibility Testing; Environmental Testing; Mechanical Safety Testing; Performance Testing; Software Validation Testing; Chemical Characterization Testing2) By Inspection: Pre-Market Inspection; In-Process Inspection; Final Product Inspection; Supplier Audit and Evaluation; Manufacturing Site Inspection; Quality System Inspection
3) By Certification: International Organization for Standardization (ISO) 13485 Certification; Conformité Européenne (CE) Marking; Food and Drug Administration (FDA) Premarket Approval (PMA) Support; Medical Device Single Audit Program (MDSAP) Certification; International Electrotechnical Commission (IEC) 60601 Certification; European Union (EU) Medical Device Regulation (MDR) Compliance Certification; Product Safety Certification
Companies Mentioned: Thermo Fisher Scientific; Medtronic plc; Baxter International; SGS SA; Eurofins Scientific SE; Bureau Veritas SA; Bausch & Lomb; Intertek Group plc; TÜV SÜD AG; Underwriters Laboratories LLC; Applus+ Group; BSI Group ; NSF International ; NEMKO AS; Smithers Group Inc.; Laboratory Testing Inc.; JPen Medical Inc.; ArchiMed; F2 Labs Inc.; Medistri SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Device Safety Testing market report include:- Thermo Fisher Scientific
- Medtronic plc
- Baxter International
- SGS SA
- Eurofins Scientific SE
- Bureau Veritas SA
- Bausch & Lomb
- Intertek Group plc
- TÜV SÜD AG
- Underwriters Laboratories LLC
- Applus+ Group
- BSI Group
- NSF International
- NEMKO AS
- Smithers Group Inc.
- Laboratory Testing Inc.
- JPen Medical Inc.
- ArchiMed
- F2 Labs Inc.
- Medistri SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.1 Billion |
| Forecasted Market Value ( USD | $ 14.05 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |


